Gen Ilac Veglik Urunlerinayi ve Ticaret AS (IST:GENIL) 3-Year EBITDA Growth Rate : 40.60% (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Gen Ilac Veglik Urunlerinayi ve Ticaret AS 3-Year EBITDA Growth Rate?

Gen Ilac Veglik Urunlerinayi ve Ticaret AS's EBITDA per Share for the three months ended in Dec. 2023 was ₺0.21.

During the past 12 months, Gen Ilac Veglik Urunlerinayi ve Ticaret AS's average EBITDA Per Share Growth Rate was 9.10% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 40.60% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 52.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 6 years, the highest 3-Year average EBITDA Per Share Growth Rate of Gen Ilac Veglik Urunlerinayi ve Ticaret AS was 66.00% per year. The lowest was 40.60% per year. And the median was 55.60% per year.

Competitive Comparison of Gen Ilac Veglik Urunlerinayi ve Ticaret AS's 3-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Gen Ilac Veglik Urunlerinayi ve Ticaret AS's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Gen Ilac Veglik Urunlerinayi ve Ticaret AS's 3-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Gen Ilac Veglik Urunlerinayi ve Ticaret AS's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Gen Ilac Veglik Urunlerinayi ve Ticaret AS's 3-Year EBITDA Growth Rate falls into.

Gen Ilac Veglik Urunlerinayi ve Ticaret AS 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Gen Ilac Veglik Urunlerinayi ve Ticaret AS (IST:GENIL) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Gen Ilac Veglik Urunlerinayi ve Ticaret AS 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Gen Ilac Veglik Urunlerinayi ve Ticaret AS's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Gen Ilac Veglik Urunlerinayi ve Ticaret AS (IST:GENIL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Gen Ilac Ve Saglik Urunleri Sanayi ve Ticaret AS (IST:GENIL) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

Mustafa Kemal Mahallesi 2119.Sk. No:3, Cankaya, Ankara, TUR, 06520

Website

https://www.genilac.com.tr

Gen Ilac Ve Saglik Urunleri Sanayi ve Ticaret AS is a specialty pharmaceuticals company in Turkey. Its locally manufactured products include Cajex, Contra-K, Epamor, Genkort, Ilopera, among others, while imported products include AvonexPEN, Plegridy, Tecfidera, Regen-D among others.

Gen Ilac Veglik Urunlerinayi ve Ticaret AS (IST:GENIL) Headlines

No Headlines